There's a new precaution section for Gleevec
The occasional occurrence of severe congestive heart failure and left ventricular dysfunction with use of imatinib (Gleevec) has prompted manufacturer Novartis to revise the Precautions section of the prescribing information. According to the company, most patients experiencing cardiac events had other comorbidities and risk factors, including a prior medical history of cardiac disease and advanced age. At-risk patients should be monitored carefully, and any patients with signs or symptoms consistent with cardiac failure should be evaluated and treated.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Q&A: Pharmacist-Led Diabetes Management Transforms Patient Care and Clinical Outcomes
June 28th 2025An ambulatory care pharmacist program in Washington State dramatically improved diabetes management by reducing A1c levels, increasing medication adherence, and providing comprehensive patient education.
